[Assessment of efficiency of patients' therapeutic education in chronic heart failure treatment].

Patients' therapeutic education is one of the modern approaches to improvement of quality of chronic heart failure (CHF) treatment. Purpose of the study was evaluation of the effect of therapeutic education on life quality and need of rehospitalization in patients with CHF. 57 patients with CHF of NYHA III-IV functional class (FC) randomized in two - intervention and control groups - were observed.

[Angiotensin-converting enzyme inhibitor treatment of heart failure due to dilated cardiomyopathy].

Unlabelled: To assess effects of enalapril and Accupro on clinical status left ventricular remodeling and systolic function in patients with heart failure due to dilated cardiomyopathy.

Study Structure: Randomized, open, controlled, duration -- 6 months.

Patients: 31 patients with dilated cardiomyopathy (mean age 46+/-2 years).

[Improvement of the vaccine prevention quality as a basis of the social welfare].

Basic trends of morbidity by infectious diseases and the state of vaccine prevention has been studied in different developed and developing countries including Georgia. For analysis all the available special literature and internet materials concerning Georgian population were worked out. Analysis of the organization of the vaccination in our country proved that vaccine prevention of the infectious disease must be carried out not only in children but in adult population as well.

[Effects of Accupro on structural and hemodynamic changes in patients with chronic heart failure].

The efficacy of angiotensin converting-enzyme inhibitors in the therapy of chronic heart failure are well documented and is mainly explained by a decrease of afterload via reduction of angiotensin II formation in the vascular system and myocardium. The aim of our study was to study the effectiveness of ACCUPRO on structural and hemodynamic indices in patients with heart failure. 37 patients aged 61-84 years with postinfarction cardiosclerosis and mild or moderate hypertension, class I-III heart failure received Accupro (13,7+/-0,97 mg/day) for 3 months in combination with furosemide (40-80 mg 1-3 times a week).